TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
FBRX

Forte Biosciences Inc

Healthcare · Biotechnology

77.00$ +0.0% vs. previous close Closing price · As of: Aug 28, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement FBRX
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0%
30.6%
100.0% 100.0% 100.0% 100.0% -30.6%
37,592.2% 55,546.9% 71,007.3% 279.7% 7,425.0%
7,515.7% 9,228.6% 20,870.7% 1.5% 3,834.2%
44,652.9% 64,255.1% 91,165.9% 350.8% 11,258.3%
-45,007.8% -64,675.5% -91,778.0% -254.2% -11,288.9%
200.0% 3,749.0% 4,712.2% 1.0% 10,611.1%
-45,207.8% -68,322.4% -94,948.8% -262.0% -11,302.8%
-400.0% -7,498.0% -6,341.5% 9.4% -7.0%
-45,207.8% -68,322.4% -94,948.8% -271.4% -11,302.8%
-44,088.2% -63,614.3% -89,524.4% -242.3% -11,272.2%

Data as of: August 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?